Tarsus Pharmaceuticals, Inc. (TARS) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は Vivo Capital Fund IX, L.P. 2,469,001 株保有. その他の主要保有者には Vivo Capital IX, LLC および RTW INVESTMENTS, LP.
過去12ヶ月間にインサイダーは 67 件の取引を実施 TARS 株式 — 17 件の買い (評価額 RSU アワード) および 33 件の売り (評価額 $10.07M). インサイダーの売りが買いを上回っています.
TARS インサイダー保有状況
最大保有者
Vivo Capital Fund IX, L.P.
2,469,001 株
インサイダー上位保有者
| # |
氏名 |
役職 |
保有株数 |
最終申告日 |
相対規模 |
| 1 |
Vivo Capital Fund Ix, L.p. |
Director |
2,469,001 |
2022-05-05 |
|
| 2 |
Vivo Capital Ix, Llc |
10 Percent Owner |
2,469,001 |
2022-05-05 |
|
| 3 |
Rtw Investments, Lp |
10 Percent Owner |
2,013,601 |
2021-05-07 |
|
| 4 |
Link William J Phd |
Director |
116,332 |
2026-03-18 |
|
| 5 |
Neervannan Seshadri |
Chief Operating Officer |
82,791 |
2026-03-24 |
|
| 6 |
Wahl Bryan |
General Counsel |
72,315 |
2026-03-19 |
|
| 7 |
Mottiwala Aziz |
Chief Commercial Officer |
70,250 |
2026-03-19 |
|
| 8 |
Azamian Bobak R. |
President/ceo and Board Chair |
57,052 |
2026-03-19 |
|
| 9 |
Farrow Jeffrey S |
See Remarks |
47,635 |
2026-03-19 |
|
| 10 |
Whitfield Dianne C. |
Chief Human Resources Officer |
43,273 |
2026-03-19 |
|
| 11 |
Greenstein Leonard M. |
Chief Financial Officer |
26,785 |
2023-04-21 |
|
| 12 |
Lin Elizabeth Yeu |
Chief Medical Officer |
24,077 |
2026-03-19 |
|
| 13 |
Tester Jason E. |
10 Percent Owner |
10,000 |
2021-06-17 |
|
| 14 |
Ackermann Michael |
Director |
7,000 |
2022-07-01 |
|
| 15 |
Pyott David E I |
Director |
3,729 |
2026-02-20 |
|
| 16 |
Holdbrook Mark J. |
V.p., Clinical Affairs |
3,389 |
2023-03-21 |
|
| 17 |
Crane Rosemary A |
Director |
3,350 |
2024-06-14 |
|
| 18 |
Goldberg Andrew D. |
Director |
2,954 |
2025-06-16 |
|
| 19 |
Chaudhuri Bhaskar |
Director |
2,954 |
2025-06-16 |
|
| 20 |
Yarno Wendy L |
Director |
2,954 |
2025-06-16 |
|
最近の取引 (過去12ヶ月)
| 日付 |
氏名 |
役職 |
種類 |
株数 |
株価 |
価値 |
| 2026-03-20 |
Neervannan Seshadri |
Chief Operating Officer |
情報に基づく売り |
2,989 |
$66.75 |
$199.52K |
| 2026-03-19 |
Lin Elizabeth Yeu |
Chief Medical Officer |
情報に基づく売り |
390 |
$67.00 |
$26.13K |
| 2026-03-18 |
Lin Elizabeth Yeu |
Chief Medical Officer |
情報に基づく売り |
379 |
$68.71 |
$26.04K |
| 2026-03-17 |
Lin Elizabeth Yeu |
Chief Medical Officer |
情報に基づく売り |
375 |
$69.42 |
$26.03K |
| 2026-03-19 |
Wahl Bryan |
General Counsel |
情報に基づく売り |
4,231 |
$67.00 |
$283.48K |
| 2026-03-18 |
Wahl Bryan |
General Counsel |
情報に基づく売り |
4,125 |
$68.71 |
$283.43K |
| 2026-03-17 |
Wahl Bryan |
General Counsel |
情報に基づく売り |
4,084 |
$69.42 |
$283.51K |
| 2026-03-19 |
Whitfield Dianne C. |
Chief Human Resources Officer |
情報に基づく売り |
4,174 |
$67.00 |
$279.66K |
| 2026-03-18 |
Whitfield Dianne C. |
Chief Human Resources Officer |
情報に基づく売り |
4,071 |
$68.71 |
$279.72K |
| 2026-03-17 |
Whitfield Dianne C. |
Chief Human Resources Officer |
情報に基づく売り |
4,029 |
$69.42 |
$279.69K |
| 2026-03-19 |
Azamian Bobak R. |
President/ceo and Board Chair |
情報に基づく売り |
11,964 |
$67.00 |
$801.59K |
| 2026-03-18 |
Azamian Bobak R. |
President/ceo and Board Chair |
情報に基づく売り |
11,667 |
$68.71 |
$801.64K |
| 2026-03-17 |
Azamian Bobak R. |
President/ceo and Board Chair |
情報に基づく売り |
10,972 |
$69.42 |
$761.68K |
| 2026-03-19 |
Neervannan Seshadri |
Chief Operating Officer |
情報に基づく売り |
4,589 |
$67.00 |
$307.46K |
| 2026-03-18 |
Neervannan Seshadri |
Chief Operating Officer |
情報に基づく売り |
3,610 |
$68.71 |
$248.04K |
| 2026-03-17 |
Neervannan Seshadri |
Chief Operating Officer |
情報に基づく売り |
3,125 |
$69.42 |
$216.94K |
| 2026-03-19 |
Mottiwala Aziz |
Chief Commercial Officer |
情報に基づく売り |
4,440 |
$67.00 |
$297.48K |
| 2026-03-18 |
Mottiwala Aziz |
Chief Commercial Officer |
情報に基づく売り |
4,330 |
$68.71 |
$297.51K |
| 2026-03-17 |
Mottiwala Aziz |
Chief Commercial Officer |
情報に基づく売り |
4,286 |
$69.42 |
$297.53K |
| 2026-03-19 |
Farrow Jeffrey S |
See Remarks |
情報に基づく売り |
2,186 |
$67.00 |
$146.46K |
| 2026-03-18 |
Farrow Jeffrey S |
See Remarks |
情報に基づく売り |
2,133 |
$68.71 |
$146.56K |
| 2026-03-17 |
Farrow Jeffrey S |
See Remarks |
情報に基づく売り |
2,111 |
$69.42 |
$146.55K |
| 2026-03-16 |
Link William J Phd |
Director |
情報に基づく売り |
493 |
$69.75 |
$34.39K |
| 2026-03-15 |
Lin Elizabeth Yeu |
Chief Medical Officer |
オプション行使（売却） |
2,511 |
- |
- |
| 2026-03-15 |
Wahl Bryan |
General Counsel |
オプション行使（売却） |
4,790 |
- |
- |
